Clinical Trial

Biomarkers, Risk Assessment, Imaging, and Neurodegeneration in Cerebral Small Vessel Disease (BRAIN-CSVD)

Study acronym: BRAIN-CSVD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The BRAIN-CSVD study is a single-center prospective cohort study focusing on cerebral small vessel disease (CSVD).Patients enrolled in this research will undergo assessments for vascular risk factors, cognitive and other neurological functions, neuroimaging, and biomarkers. The study aims to explore imaging and biomarker predictors of CSVD progression, and the pathophysiological mechanisms of CSVD.
Trial Details
NCT Number NCT07093515
Lead Sponsor Zhejiang Hospital
Conditions Cerebral Small Vessel Disease
Enrollment 500 participants
Start Date 2025-10
Primary Completion 2030-12-30 (estimated)
Study Completion 2032-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-30